- Home
- FBRX vs NMAI Comparison
FBRX vs NMAI Comparison
Compare FBRX & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBRX | NMAI |
|---|---|---|
| Founded | N/A | 2021 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.4M | 440.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FBRX | NMAI |
|---|---|---|
| Price | $30.22 | $13.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 244.9K | 74.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.03 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.90 | $10.60 |
| 52 Week High | $35.62 | $12.55 |
Technical Indicators
Market Signals| Indicator | FBRX | NMAI |
|---|---|---|
| Relative Strength Index (RSI) | 50.83 | 56.89 |
| Support Level | $27.88 | $13.37 |
| Resistance Level | $31.19 | $13.96 |
| Average True Range (ATR) | 3.67 | 0.16 |
| MACD | -0.36 | 0.00 |
| Stochastic Oscillator | 40.33 | 47.86 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.